596 related articles for article (PubMed ID: 2876788)
1. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
Bristow MR; Ginsburg R; Umans V; Fowler M; Minobe W; Rasmussen R; Zera P; Menlove R; Shah P; Jamieson S
Circ Res; 1986 Sep; 59(3):297-309. PubMed ID: 2876788
[TBL] [Abstract][Full Text] [Related]
2. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
Bristow MR; Hershberger RE; Port JD; Minobe W; Rasmussen R
Mol Pharmacol; 1989 Mar; 35(3):295-303. PubMed ID: 2564629
[TBL] [Abstract][Full Text] [Related]
3. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
4. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV
J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR
Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
[TBL] [Abstract][Full Text] [Related]
7. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure.
Atkins FL; Bing OH; DiMauro PG; Conrad CH; Robinson KG; Brooks WW
Hypertension; 1995 Jul; 26(1):78-82. PubMed ID: 7607736
[TBL] [Abstract][Full Text] [Related]
8. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart.
Ogletree-Hughes ML; Stull LB; Sweet WE; Smedira NG; McCarthy PM; Moravec CS
Circulation; 2001 Aug; 104(8):881-6. PubMed ID: 11514373
[TBL] [Abstract][Full Text] [Related]
9. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
10. Human Myocardium Has a Robust α1A-Subtype Adrenergic Receptor Inotropic Response.
Janssen PML; Canan BD; Kilic A; Whitson BA; Baker AJ
J Cardiovasc Pharmacol; 2018 Sep; 72(3):136-142. PubMed ID: 29923888
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
[TBL] [Abstract][Full Text] [Related]
13. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
[TBL] [Abstract][Full Text] [Related]
14. Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive.
Wang GY; Yeh CC; Jensen BC; Mann MJ; Simpson PC; Baker AJ
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H913-20. PubMed ID: 20035030
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
16. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
Müller-Ehmsen J; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
[TBL] [Abstract][Full Text] [Related]
17. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.
Gong H; Sun H; Koch WJ; Rau T; Eschenhagen T; Ravens U; Heubach JF; Adamson DL; Harding SE
Circulation; 2002 May; 105(21):2497-503. PubMed ID: 12034656
[TBL] [Abstract][Full Text] [Related]
18. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
[TBL] [Abstract][Full Text] [Related]
19. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.
Asano K; Dutcher DL; Port JD; Minobe WA; Tremmel KD; Roden RL; Bohlmeyer TJ; Bush EW; Jenkin MJ; Abraham WT; Raynolds MV; Zisman LS; Perryman MB; Bristow MR
Circulation; 1997 Mar; 95(5):1193-200. PubMed ID: 9054849
[TBL] [Abstract][Full Text] [Related]
20. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
